Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes.

Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2020)

Keyphrases